Breast Ductal Carcinoma In Situ — Trials

Breast Ductal Carcinoma In Situ — Trials · CancerIndex

Clinical trials

Registered studies

163 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 51
Recruiting: 27
Ph III recruiting: 2
Growth YoY: —
Industry share: 4%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (28)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06218303	Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ	recruiting	Phase 1	50	Finn, Olivera, PhDOTHER	1	Aug 18, 2026	clinicaltrials
NCT04144023	A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ	recruiting	Phase 1	43	Mayo ClinicOTHER	1	Mar 5, 2026	clinicaltrials